Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

54.60
Delayed Data
As of Feb 27
 +1.22 / +2.29%
Today’s Change
42.67
Today|||52-Week Range
85.83
+9.59%
Year-to-Date
No recent news for Mallinckrodt Plc.

Today’s Trading

Previous close53.38
Today’s open53.62
Day’s range53.52 - 54.90
Volume1,788,315
Average volume (3 months)2,342,624
Market cap$5.7B
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.42%
Revenue growth (last year)+1.01%
P/E ratio29.8
Price/Sales2.30
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.53+3.28%
IONSIonis Pharmaceutical...+2.31+5.18%
ACADACADIA Pharmaceutica...+0.97+2.49%
OPKOPKO Health Inc+0.20+2.37%
Data as of 02/27/2017

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$1.63
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts


Search for Jobs